Showing results (161-170 of 215) with videos related to
Sort By:
Pageof 22
Neuro-Oncology|December 7, 2007
Positron emission tomography-guided conformal fast neutron therapy for glioblastoma multiformeKeith J Stelzer, James G Douglas, David A Mankoff, et al.Journal of Neuro-Oncology|June 14, 2015
Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patientsFahed Zairi, Emilie Le Rhun, Nicolas Bertrand, et al.Neuropsychologia|January 22, 2008
Category-specific naming and recognition deficits in temporal lobe epilepsy surgical patientsDaniel L Drane, George A Ojemann, Elizabeth Aylward, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 22, 2020
Evaluating angioarchitectural characteristics of glial and metastatic brain tumors with conventional magnetic resonance imagingIsaac Josh Abecassis, Benjamin Cordy, Sharon Durfy, et al.CNS Oncology|October 27, 2015
Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patientsEmilie Le Rhun, Marc C Chamberlain, Fahed Zairi, et al.Clinical Lymphoma, Myeloma & Leukemia|February 8, 2017
Posterior Reversible Encephalopathy Syndrome Associated With Dose-adjusted EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) ChemotherapyAbby E Floeter, Amila Patel, Melinda Tran, et al.Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.Cancer|August 1, 2009
Gender disparity in the rate of partner abandonment in patients with serious medical illnessMichael J Glantz, Marc C Chamberlain, Qin Liu, et al.Journal of Neuro-Oncology|April 18, 2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)Marc C Chamberlain, Sean Grimm, Surasak Phuphanich, et al.Science Translational Medicine|May 11, 2012
Extended survival of glioblastoma patients after chemoprotective HSC gene therapyJennifer E Adair, Brian C Beard, Grant D Trobridge, et al.Pageof 22